Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Coherus Biosciences Popped Today

TheMotleyFool 
0 0 22.01.24
Why Coherus Biosciences Popped Today: https://g.foolcdn.com/editorial/images/762174/divest-divestment-sri-esg-sustainability-socially-conscious.jpg
 

Shares of (NASDAQ: CHRS) rallied as much as 21.7% early Monday, then gave up its gains to trade up around 2.4% as of 2:40 p.m. ET. This occurred after the company announced an agreement to divest its ophthalmology franchise.

In a press release this morning, Coherus announced a deal to divest its Cimerli franchise, a biosimilar drug to treat vision impairment and loss, to biosimilars company Sandoz Group (OTC: SDZN.Y). The latter will pay Coherus $170 million in cash up front for Cimerli and its supporting commercial infrastructure, plus an additional amount (to be determined at closing) for working capital adjustments and Cimerli product inventory.

Coherus entered the ophthalmology market in 2022, gaining significant market share in the non-core area of its business.

Continue reading


Source Fool.com

Coherus Bioscien. Stock

€1.28
-9.090%
Coherus Bioscien. took a tumble today and lost -€0.128 (-9.090%).

Show more
Like: 0
CHRS
Share

Comments

Not a member yet? Sign up for free!